SCL
Get informed when a big investor buys or sells
+ FollowOvervalued by 173% based on the discounted cash flow analysis.
| Market cap | $1.23 Billion |
|---|---|
| Enterprise Value | $1.55 Billion |
| Dividend Yield | $1.57 (2.91%) |
| Earnings per Share | $2.05 |
| Beta | 0.97 |
| Outstanding Shares | 22,888,000 |
| P/E Ratio | -86.81 |
|---|---|
| PEG | 28 |
| Price to Sales | 0.52 |
| Price to Book Ratio | 1.01 |
| Enterprise Value to Revenue | 0.66 |
| Enterprise Value to EBIT | 38.63 |
| Enterprise Value to Net Income | -110 |
| Total Debt to Enterprise | 0.21 |
| Debt to Equity | 0.28 |
No data
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.0815▲ 3.98% |
|---|---|
| Total Calls | 130,000▲ 2.44% |
| Total Puts | 10,600▲ 100.00% |
Holdings and activity of institutional investors.
| Ownership % | 85.90%▲ 1.33% |
|---|---|
| Total Invested | $981.85M▲ 7.18% |
| Investors Holding | 227▲ 13.00% |
No data
Sets corporate tax rates and trade/tariff policies that directly impact the cost of imported raw materials and the competitiveness of exports.
Oversees the FDA, which regulates surfactants used in personal care and food products, and labor laws that impact manufacturing costs.
Directly regulates the EPA, which oversees the Toxic Substances Control Act (TSCA) and emissions standards that govern chemical manufacturing operations.